| Literature DB >> 1440822 |
P Kraivichian1, M Kulkumthorn, P Yingyourd, P Akarabovorn, C C Paireepai.
Abstract
The efficacy of albendazole was investigated in 112 patients with symptomatic gnathostomiasis; 49 received 400 mg twice daily, 51 received 400 mg once daily, and 12 patients received placebo, all for 21 d. Subsequent follow-up was for 6 months. Cure (no further swelling) was seen in 93.9% and 94.1% of the treatment groups but in none of the placebo group. Additionally, reductions in eosinophil counts and in immunoglobulin G antibody were observed after treatment. Side effects were minimal. Albendazole may be an effective compound for the treatment of gnathostomiasis.Entities:
Mesh：
Substances：
Year: 1992 PMID： 1440822 DOI： 10.1016/0035-9203(92)90248-b
Source DB: PubMed Journal: Trans R Soc Trop Med Hyg ISSN： 0035-9203 Impact factor: 2.184